양극성 장애 1형에서 종양괴사인자 베타 유전자 다형성 = Polymorphism of Tumor Necrosis Factor-β Gene in Bipolar I disorder

다국어 초록 (Multilingual Abstract)

Objectives : Bipolar disorder is known to have a high genetic predisposition. Recently, the main focus of etiologic studies in bipolar disorder has been concentrated on molecular genetic approach including gene polymorphism analysis. The present study was conducted to investigate whether TNFB polymorphism is associated with bipolar I disorder in the Korean population.
Methods : 89 bipolar I disorder patients diagnosed by DSM-IV criteria were assigned as the patient group and 202 normal population, matched on age and sex from Catholic hemopoietic stem cell bank (Seoul, Korea), were enrolled as the control group in this study. Genotyping was performed by a polymerase chain reaction-restriction fragment length polymorphism method. All data was analyzed by x² test.
Results : There were no significant differences in frequency of TNFB*1/1,TNFB*1/2 and TNFB*2/2 between bipolar I disorder patient group and normal control group. The frequency of TNFB*1 was not statistically different between bipolar I disorder patient group and normal control group.
Conclusion : The difference of frequency in TNFB*1/TNFB*2 gene between the bipolar I disorder gropup and the normal contro1 could not be verified. The present result suggested that the gene polymorphism of TNFB may not play a significant role in susceptibility to bipolar I disorder. Studies with a larger number of subjects from different ethnic backgrounds, considring clinical phenotype and controlling various factors, should be launched to further determine the role of TNFB in bipolar I disorder.

참고문헌 (Reference)

1 "정신분열병에서 종양괴사인자 베타 유전자의 제한효소 절편길이 다형성" 40 : 341-346, 2001

2 "physicalmanifestation of bipolar affective disorder" 887-891, neuropsychopharmacolbiolpsychiatry1988

3 "Visualization andcharacterization of interleukin 1 receptors in brain" 139 : 459-463, 1987

4 "Theeffect of TNF*B gene polymorphism on TNF-alpha and -beta secretionlevels in patients with insulin-dependent diabetes mellitus andhealthy controls" 23 : 425-435, 1996

5 "The neuropsychiatric effects of treatment with interleukin-2and lymphokine-activated killer cells" 107 : 293-300, 1987

6 "The interaction between depressive affectivedisorder and neuropsychological test performance in multiple sclerosispatients" 3 : 28-32, 1991

7 "The gene polymorphismof tumor necrosis factor-beta,but not that of tumor necrosisfoactor-alpha,is associated with the prognosis of sarcoidosis" 119 : 753-761, 2001

8 "The future of genetic studies of complex humandisease" 273 : 1516-1517, 1996

9 "T-helper types 1,2,and 3 cytokine interactions in symptomatic manicpatients" 129 : 267-272, 2004

10 "Reducedcellular immune function in major depression and mania" 235-237, psychiatryres1989

11 "Polymorphism within the tumor necrosis factor locus and prevalenceof coronary artery disease in middle-aged men" 154 : 691-697, 2001

12 "Polymorphic structure of the tumor necrosis factor an NcoI polymorphism in the first intron of the human TNF-β genecorrelates with a variant amino acid in position 26 and a reduced levelof TNF-β production" 209-219, jexpmed1991

13 "Polymorphic MHC ancestralhaplotypes affect the activity of tumor necrosis factor-alpha" 92 : 14-18, 1993

14 "Leukaemia inhibitoryfactor mRNA is expressed in the brains of patients with subacutesclerosing panencephalitis" 77 : 57-62, 1997

15 "Interleukin-10 and tumor necrosis factor gene polymorphismsand risk of coronary artery disease and myocardial infarction.Atherosclerosis" 159 : 137-144, 2001

16 "Interleukin-1 immunoreactiveinnervation of the human hypothalamus" 240 : 321-324, 1988

17 "Increased plasma concentrations ofIL-6,soluble IL-6 receptor,soluble IL-2 receptor and transferrin receptorin major depression" 34 : 301-309, 1995

18 "Immune function in mania" 24 : 314-343, Psychiatry1988

19 "Humoral autoimmune phenomena under longterm treatment with lithium with special regard to thyroid auto antibodies" 60 : 1501-1504, 1982

20 "Hashimoto’s encephalopathy presenting as "myxodematous madness"J Neurol Neurosurg Psychiatry" 68 : 102-103, jneurolneurosurgpsychiatry2000

21 "Effect of lithium carbonate therapy on thyroid immunestatus in manic depressive patients:a prospective study" 11 : 155-160, Disord1986

22 "Differential effect of mixed D1/D2 and selective D2 dopaminergic antagonists on mouse T and Blymphocyte proliferation and interleukin production in vitro" 10 : 501-512, 1988

23 "Cytokine production in bipolar affective disorder patients under lithiumtreatment" 82 : 309-313, 2004

24 "Comprehensive Textbook of Psychiatry" Lippincott Williams & Wilkins 1308-1309, 2001

25 "Chronic lithium-induced downregulation ofMARCKS in immortalized Hippocampal cells:potentiation by muscarinicreceptor activation" 67 : 767-777, 1996

26 "Anti-bipolar therapy:mechanism of action of lithium" 4 : 117-128, 1999

27 "Allelic variation in the TNF-β gene does not explain the lowTNF-β responses in patients with primary biliary cirrhosis" 34 : 735-740, 1991

28 "Activationof indices of cell-mediated immunity in bipolar disorder" 45 : 989-994, 1999

29 "A simple salting out procedure forextracting DNA from human nucleated acid" 16 : 1215-, 1988